allo-asc-dfu
Cell therapyexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 30, 2018 (NCT03754465)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04569409 | Phase 3 | Jul 14, 2020 | Anterogen Co., Ltd., Catholic University of Korea, Korea University, Seoul National University, University of Ulsan |
| NCT03754465 | Phase 2 | Nov 30, 2018 | Anterogen Co., Ltd., University of Southern California |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anterogen Co., Ltd. | For profit | 2 | 2 | 2 | 2018 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Southern California | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2020 |
6 organizations
Page 1 / 1